Identifying Women Most Likely To Respond To Preventive Breast Cancer Therapy

[News]

Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery...

More... (http://www.medicalnewstoday.com/releases/261956.php)